Additionally, evasion of autophagy and cell migration are emerging areas in the study of trastuzumab resistance, involving signal transduction of various kinases and scaffolding proteins, providing a broad research field and potential for developing novel, more specific treatment strategies to intervene in the progression and metastasis of HER2-positive breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.